Annual Total Debt
$49.16 M
-$3.00 M-5.75%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual total debt is $49.16 million, with the most recent change of -$3.00 million (-5.75%) on December 31, 2023.
- During the last 3 years, TBPH annual total debt has fallen by -$627.10 million (-92.73%).
- TBPH annual total debt is now -92.73% below its all-time high of $676.26 million, reached on December 31, 2020.
Performance
TBPH Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$44.98 M
-$1.68 M-3.60%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly total debt is $44.98 million, with the most recent change of -$1.68 million (-3.60%) on September 30, 2024.
- Over the past year, TBPH quarterly total debt has dropped by -$5.85 million (-11.51%).
- TBPH quarterly total debt is now -93.37% below its all-time high of $677.96 million, reached on June 30, 2022.
Performance
TBPH Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TBPH Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | -11.5% |
| 3 y3 years | -92.7% | -93.3% |
| 5 y5 years | -89.2% | -93.3% |
TBPH Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.7% | at low | -93.4% | at low |
| 5 y | 5-year | -92.7% | at low | -93.4% | at low |
| alltime | all time | -92.7% | -100.0% | -93.4% | -100.0% |
Theravance Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.98 M(-3.6%) |
| Jun 2024 | - | $46.66 M(-2.6%) |
| Mar 2024 | - | $47.90 M(-2.6%) |
| Dec 2023 | $49.16 M(-5.8%) | $49.16 M(-3.3%) |
| Sep 2023 | - | $50.83 M(-1.6%) |
| Jun 2023 | - | $51.68 M(+1.0%) |
| Mar 2023 | - | $51.19 M(-1.9%) |
| Dec 2022 | $52.16 M(-92.2%) | $52.16 M(+0.2%) |
| Sep 2022 | - | $52.07 M(-92.3%) |
| Jun 2022 | - | $677.96 M(+0.7%) |
| Mar 2022 | - | $672.95 M(+0.5%) |
| Dec 2021 | $669.52 M(-1.0%) | $669.52 M(-0.3%) |
| Sep 2021 | - | $671.24 M(+0.4%) |
| Jun 2021 | - | $668.31 M(-0.6%) |
| Mar 2021 | - | $672.32 M(-0.6%) |
| Dec 2020 | $676.26 M(+32.5%) | $676.26 M(+1.1%) |
| Sep 2020 | - | $668.68 M(+1.6%) |
| Jun 2020 | - | $658.07 M(+0.4%) |
| Mar 2020 | - | $655.16 M(+28.3%) |
| Dec 2019 | $510.53 M(+12.4%) | $510.53 M(-0.2%) |
| Sep 2019 | - | $511.78 M(-0.0%) |
| Jun 2019 | - | $511.87 M(+1.7%) |
| Mar 2019 | - | $503.28 M(+10.8%) |
| Dec 2018 | $454.35 M | $454.35 M(+102.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $224.55 M(+0.1%) |
| Jun 2018 | - | $224.28 M(+0.1%) |
| Mar 2018 | - | $224.01 M(+0.1%) |
| Dec 2017 | $223.75 M(+0.5%) | $223.75 M(+0.1%) |
| Sep 2017 | - | $223.48 M(+0.1%) |
| Jun 2017 | - | $223.21 M(+0.1%) |
| Mar 2017 | - | $222.94 M(+0.1%) |
| Dec 2016 | $222.68 M(>+9900.0%) | $222.68 M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00 |
| Dec 2012 | $0.00 | - |
FAQ
- What is Theravance Biopharma annual total debt?
- What is the all time high annual total debt for Theravance Biopharma?
- What is Theravance Biopharma annual total debt year-on-year change?
- What is Theravance Biopharma quarterly total debt?
- What is the all time high quarterly total debt for Theravance Biopharma?
- What is Theravance Biopharma quarterly total debt year-on-year change?
What is Theravance Biopharma annual total debt?
The current annual total debt of TBPH is $49.16 M
What is the all time high annual total debt for Theravance Biopharma?
Theravance Biopharma all-time high annual total debt is $676.26 M
What is Theravance Biopharma annual total debt year-on-year change?
Over the past year, TBPH annual total debt has changed by -$3.00 M (-5.75%)
What is Theravance Biopharma quarterly total debt?
The current quarterly total debt of TBPH is $44.98 M
What is the all time high quarterly total debt for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total debt is $677.96 M
What is Theravance Biopharma quarterly total debt year-on-year change?
Over the past year, TBPH quarterly total debt has changed by -$5.85 M (-11.51%)